mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.005 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.005 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.005 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.005 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.007 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.007 |
mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.007 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.008 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.008 |
mRNA |
OSI-930 |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.008 |